A Randomized, Double-Blind, Placebo-Controlled Study of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal, and Postmenopausal Women With Thinning Hair

January 2021 | Volume 20 | Issue 1 | Original Article | 55 | Copyright © January 2021

Published online December 30, 2020

Glynis Ablon MD FAADa, Sophia Kogan MDb

aAblon Skin Institute and Research Center, Manhattan Beach, CA
bNutraceutical Wellness Inc., New York, NY

assessment questionnaires, suggesting sustained and perhaps even enhanced improvement may occur with continued use. This hypothesis, along with other potential long-term benefits of the nutraceutical, will be evaluated in the six-month open-label extension phase of the current study scheduled to be completed by 2020.

The supplement was well-tolerated. An overwhelming majority of subjects taking the active product not only found it to be more convenient to incorporate into their daily routine over using a topical application, but also preferred taking a natural alternative – underscoring the need for efficacious nutraceutical formulations. Furthermore, this emphasizes the importance of selecting tailored supplements that have clinical data on phytoactivity, bioavailability, standardized dosing, bio- optimization, and potency.12 


The results of this study demonstrate the ability of a novel nutraceutical supplement with bio-optimized phytoactive ingredients to safely and effectively improve hair growth and quality in perimenopausal, menopausal, and postmenopausal women with thinning hair. The number of total, terminal, and vellus hair counts, and hair shedding all significantly improved compared to placebo. Investigator global ratings for hair growth and quality were significantly higher for subjects in the active treatment group compared to placebo. The supplement was found to be well-tolerated, safe, and easily incorporated into daily routines.


Dr. Glynis Ablon received a research grant for the study. Dr. Sophia Kogan is a researcher at Nutraceutical Wellness, Inc.


The author acknowledges the editorial assistance of Dr. Carl S. Hornfeldt, Apothekon, Inc., during the preparation of this manuscript. Financial support was provided by Nutraceutical Wellness, Inc.


  1. Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90:529-543.
  2. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Mary-borough. J Investig Dermatol Symp Proc. 2005;10(3):184-189.
  3. Schmitt JV, Ribeiro CF, Souza FH, et al. Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. An Bras Dermatol. 2012;87:412-417.
  4. Sadick NS, Callender VD, Kircik LH, Kogan S. New insight into the pathophysiology of hair loss trigger a paradigm shift in the treatment approach. J Drugs Dermatol. 2017;16(11):s135-s140.
  5. Ablon G, Kogan S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair. J Drugs Dermatol. 2018;17(5):558-565.
  6. Ahluwalia J, Fabi SG. The psychological and aesthetic impact of age-related hair changes in females. J Cosmet Dermatol. 2019;18:1161-1169.
  7. Bienenfeld A, Azarchi S, Lo Sicco K, et al. Androgens in women: androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80:1497-1506.
  8. Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11:e9860.
  9. Fabbrocini G, Cantelli M, Masarà A, et al. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018;4:203-211.
  10. Ali I, Wojnarowska F. Physiological changes in scalp, facial and body hair after the menopause: a cross-sectional population-based study of subjective changes. Br J Dermatol. 2011;164(3):508-513.
  11. Mirmirani P. Hormonal changes in menopause: do they contribute to a 'midlife hair crisis' in women? Br J Dermatol. 2011;165:7-11.
  12. Farris PK, Rogers N, McMichael A, Kogan S. A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals. J Drugs Dermatol. 2017;16(11):s141-s148.
  13. Ablon G. A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair. Dermatol Res Pract. 2015;2015:841570.
  14. Heinemann LA, DoMinh T, Strelow F, et al. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes. 2004;2:67.
  15. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5:334-346.
  16. Modi MB, Donga SB, Dei L. Clinical evaluation of ashokarishta, ashwagandha churna and praval pishti in the management of menopausal syndrome. Ayu. 2012;33:511-516.
  17. Auddy B ea. A standardized withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study. Journal of the American Nutraceutical Association. 2008;11(1):50-56.
  18. Akazawa N, Choi Y, Miyaki A, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012;32:795-799.
  19. Ramos PM, Brianezi G, Martins AC, et al. Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflamma- tion. Int J Cosmet Sci. 2016;38:651-654.
  20. Woods NF, Mitchell ES, Smith-Dijulio K. Cortisol levels during the menopausal transition and early post-menopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2009;16:708-718.
  21. Thom E. Stress and the hair growth cycle: cortisol-induced hair growth disruption. J Drugs Dermatol. 2016;15(8):1001-1004.
  22. El Sayed MH, Abdallah MA, Aly DG, Khater NH. Association of metabolic syndrome with female pattern hair loss in women: a case-control study. Int J Dermatol. 2016;55:1131-1137.
  23. Goluch-Koniuszy ZS. Nutrition of women with hair loss problem during the period of menopause. Prz Menopauzalny. 2016;15:56-61.
  24. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibi- tors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8:143-152.
  25. Rossi A, Mari E, Scarno M, et al. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immu- nopathol Pharmacol. 2012;25:1167-1173.
  26. Buonocore D, Verri M, Cattaneo L, et al. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for benign prostatic hyperplasia. Arch Ital Urol Androl. 2018;90:199-202.
  27. Cheng C, Shen F, Ding G, et al. Lepidiline A improves the balance of endoge- nous sex hormones and increases fecundity by targeting HSD17B1. Mol Nutr Food Res. 2020;Apr 1 [Epub ahead of print].
  28. Meissner HO, Reich-Bilinska H, Mscisz A, Kedzia B. Therapeutic effects of pre-gelatinized maca (Lepidium peruvianum chacon) used as a non-hormonal alternative to HRT in perimenopausal women - clinical pilot study. Int J Biomed Sci. 2006;2:143-159.
  29. López-Fando A, Gómez-Serranillos MP, Iglesias I, et al. Lepidium peruvianum chacon restores homeostasis impaired by restraint stress. Phytother Res. 2004;18:471-474.
  30. Zou Y, Aboshora W, Li J, et al. Protective effects of Lepidium meyenii (maca) aqueous extract and lycopene on testosterone propionate-induced prostatic hyperplasia in mice. Phytother Res. 2017;31:1192-1198.
  31. Sztretye M, Dienes B, Gönczi M, et al. Astaxanthin: a potential mitochondrial- targeted antioxidant treatment in diseases and with aging. Oxid Med Cell Longev. 2019;2019:3849692.
  32. Ng QX, De Deyn MLZQ, Loke W, et al. Effects of astaxanthin supplementation on skin health: a systematic review of clinical studies. J Diet Suppl. 2020;23:1-14.


Sophia Kogan MD sophia@nutrafol.com